| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/03/1993 | CA2091313A1 Tnf-muteins |
| 10/02/1993 | CA2093109A1 Morpholin- and thiomorpholin-4-ylamides |
| 10/02/1993 | CA2093099A1 Recombinant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
| 09/30/1993 | WO1993019373A1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 09/30/1993 | WO1993019204A1 Bovine alleles and genetic markers and methods of testing of and using same |
| 09/30/1993 | WO1993019202A2 Exchangeable template reaction |
| 09/30/1993 | WO1993019191A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 09/30/1993 | WO1993019189A1 Enhanced expression in plants |
| 09/30/1993 | WO1993019188A1 Fungus-responsive chimaeric gene |
| 09/30/1993 | WO1993019183A1 Immunization by inoculatioon of dna transcription unit |
| 09/30/1993 | WO1993019182A1 Processes for producing ribotoxins |
| 09/30/1993 | WO1993019181A1 Biological material |
| 09/30/1993 | WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 09/30/1993 | WO1993019178A2 Peptides useful for inducing tolerance |
| 09/30/1993 | WO1993019177A1 FOUR NOVEL RECEPTORS OF THE TGF-β RECEPTOR FAMILY |
| 09/30/1993 | WO1993019176A1 Leucine zippers |
| 09/30/1993 | WO1993019175A1 Receptor for the glucagon-like-peptide-1 (glp-1) |
| 09/30/1993 | WO1993019174A1 Human t-cell marker ht6 |
| 09/30/1993 | WO1993019173A1 Dna coding for aphrodisin |
| 09/30/1993 | WO1993019169A1 Genes and enzymes involved in the microbial degradation of pentachlorophenol |
| 09/30/1993 | WO1993019167A1 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells |
| 09/30/1993 | WO1993019166A1 Small animal model for studying cholesterol metabolism |
| 09/30/1993 | WO1993019165A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 09/30/1993 | WO1993019163A1 Chimeric receptor genes and cells transformed therewith |
| 09/30/1993 | WO1993019115A1 Super porous polysaccharide gels |
| 09/30/1993 | WO1993019094A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses |
| 09/30/1993 | WO1993019093A1 Peptide sequence capable of inducing a delayed-type hypersensitivity reaction in the presence of mycobacterium tuberculosis complex living bacteria, and applications |
| 09/30/1993 | WO1993019092A1 Defective recombinant adenoviruses expressing characteristic epstein-barr virus proteins |
| 09/30/1993 | WO1993019090A1 High molecular weight surface proteines of non-typeable haemophilus |
| 09/30/1993 | WO1993019089A2 Oxygen carrier |
| 09/30/1993 | WO1993019088A1 Neurotrophic peptides |
| 09/30/1993 | WO1993019087A1 Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of cap37 |
| 09/30/1993 | WO1993019086A1 Purified opioid receptor |
| 09/30/1993 | WO1993019085A1 Novel antler-derived bone growth factors |
| 09/30/1993 | WO1993019084A1 Refolding and purification of insulin-like growth factor i |
| 09/30/1993 | WO1993019079A1 Systemin |
| 09/30/1993 | WO1993018835A1 Protein purification |
| 09/30/1993 | WO1993018797A1 Method of intraoperatively detecting and locating tumoral tissues |
| 09/30/1993 | WO1993018794A1 In vivo peptide therapy |
| 09/30/1993 | WO1993018791A1 Vaccine for preventing hiv-infected disease and production thereof |
| 09/30/1993 | WO1993018788A1 An antigen for diagnosis and hyposensitisation of flea allergy dermatitis in animals |
| 09/30/1993 | WO1993018784A1 Monospecific polyclonal antibodies to shiga-like toxins |
| 09/30/1993 | WO1993018783A1 Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist |
| 09/30/1993 | WO1993018782A1 Glycosylation-mediated inhibition of factor x |
| 09/30/1993 | WO1993018759A1 A dna transporter system and method of use |
| 09/30/1993 | WO1993018643A1 Process for reducing seed storage proteins and process for transforming plants |
| 09/30/1993 | WO1993017093A3 Increasing the trehalose content of organisms by transforming them with combinations of the structural genes for trehalose synthase |
| 09/30/1993 | WO1993017040A3 Cystic fibrosis transmembrane conductance regulator (cftr) protein |
| 09/30/1993 | WO1993016180A3 Sequences for a 90k tumor-associated antigen, immunoregulin-95 (ir-95) |
| 09/30/1993 | WO1993016099A3 Dna sequences encoding novel growth/differentiation factors |
| 09/30/1993 | WO1993015203A3 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 09/30/1993 | WO1993012814A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 09/30/1993 | WO1992001049A3 Cd53 cell surface antigen and use thereof |
| 09/30/1993 | CA2132518A1 Glycosylation-mediated inhibition of factor x |
| 09/30/1993 | CA2132345A1 Oxygen carrier |
| 09/30/1993 | CA2132323A1 Fungus-responsive chimaeric gene |
| 09/30/1993 | CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 09/30/1993 | CA2132219A1 Novel antler-derived bone growth factors |
| 09/30/1993 | CA2132218A1 Peptide sequence capable of inducing a dalayed-type hypersensitivity reaction in the presence of mycobacterium tuberculosis complex living bacteria, and applications |
| 09/30/1993 | CA2132197A1 Systemin |
| 09/30/1993 | CA2132095A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 09/30/1993 | CA2131630A1 Exchangeable template reaction |
| 09/30/1993 | CA2131620A1 A dna transporter system and method of use |
| 09/30/1993 | CA2131315A1 Method of intraoperatively detecting and locating tumoral tissues |
| 09/30/1993 | CA2109820A1 Refolding and purification of insulin-like growth factor i |
| 09/29/1993 | EP0562624A2 Stabilization of functional proteins |
| 09/29/1993 | EP0562508A2 Protein with bone formation ability and process for its production |
| 09/29/1993 | EP0562373A2 Immobilisation of biochemical substances |
| 09/29/1993 | EP0562371A2 Immobilisation of biochemical substances |
| 09/29/1993 | EP0562123A1 Novel physiologically active substance epimorphine, gene which codes for same, and antibody against epimorphine |
| 09/29/1993 | EP0562056A1 Amplification of nucleic acid molecules |
| 09/29/1993 | EP0562025A1 Very large scale immobilized polymer synthesis |
| 09/29/1993 | EP0562013A1 Human retrovirus receptor and dna coding therefor |
| 09/29/1993 | EP0561971A1 Fusion polypeptides |
| 09/29/1993 | EP0561965A1 Enhancement of musculature in animals |
| 09/29/1993 | EP0561960A1 Leukemia inhibitory factor receptors |
| 09/29/1993 | EP0561953A1 Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diphtheria toxin |
| 09/29/1993 | EP0561907A1 Proteins with changed epitopes and methods for the production thereof |
| 09/29/1993 | EP0561890A1 Dna expression systems based on alphaviruses |
| 09/29/1993 | EP0561885A1 Subunit papillomavirus vaccine and peptides for use therein |
| 09/29/1993 | EP0561877A1 Compounds and compositions which inhibit bone resorption |
| 09/29/1993 | EP0561797A1 Transgenic model for selective targeting of gene products with a megakaryocyte promoter |
| 09/29/1993 | EP0480923B1 Method of producing proteins with fviii activity and/or fviii derivatives |
| 09/29/1993 | EP0382781B1 Composition for treating cancers characterized by over-expression of the c-fms proto-oncogene |
| 09/29/1993 | EP0353246B1 Sterol regulatory elements |
| 09/29/1993 | EP0305481B1 Leader sequences for the production of recombinant proteins |
| 09/29/1993 | EP0247091B1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 09/29/1993 | EP0245459B1 T-cell lymphotrophic virus protein and assay |
| 09/29/1993 | EP0185034B1 Inhibin isolated from ovarian follicular fluid |
| 09/29/1993 | CN1076629A A 90k tumor-associated antigen, ir-95 |
| 09/28/1993 | US5248772 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 09/28/1993 | US5248769 Biochemical separation or recovery |
| 09/28/1993 | US5248766 Oxirane-modified hemoglobin based composition |
| 09/28/1993 | US5248764 Cardiovascular disorders and hypotensive agents |
| 09/28/1993 | US5248670 Phosphorothioate internucleotide bonds |
| 09/28/1993 | US5248667 Method of treating psoriasis using synthetic peptide compositions |
| 09/28/1993 | US5248666 Methods for inhibiting neoplastic cell proliferation using platelet factor 4 |
| 09/28/1993 | US5248607 Monoclonal antibodies and hybridomas specific for green-oat phytochrome |
| 09/28/1993 | US5248606 Dna encoding inactive precursor and active forms of maize ribosome inactivating protein |
| 09/28/1993 | US5248599 Genetic engineering, biosynthesis |